T. Rowe Price Associates’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.27M | Buy |
|
|||||
|
2025
Q2 | $7.98M | Buy |
|
|||||
|
2025
Q1 | $9.14M | Buy |
|
|||||
|
2024
Q4 | $10.2M | Buy |
|
|||||
|
2024
Q3 | $10.5M | Sell |
|
|||||
|
2024
Q2 | $12.5M | Sell |
|
|||||
|
2024
Q1 | $15.7M | Sell |
|
|||||
|
2023
Q4 | $32.7M | Sell |
|
|||||
|
2023
Q3 | $30.4M | Buy |
|
|||||
|
2023
Q2 | $40.1M | Buy |
|
|||||
|
2023
Q1 | $24.1M | Sell |
|
|||||
|
2022
Q4 | $24.2M | Buy |
|
|||||
|
2022
Q3 | $21.8M | Buy |
|
|||||
|
2022
Q2 | $25.9M | Buy |
|
|||||
|
2022
Q1 | $39.9M | Buy |
|
|||||
|
2021
Q4 | $37.8M | Buy |
|
|||||
|
2021
Q3 | $32.3M | Buy |
|
|||||
|
2021
Q2 | $30.1M | Buy |
|
|||||
|
2021
Q1 | $1.49M | Sell |
|
|||||
|
2020
Q4 | $1.62M | Sell |
|
|||||
|
2020
Q3 | $1.15M | Sell |
|
|||||
|
2020
Q2 | $1.11M | Buy |
|
|||||
|
2020
Q1 | $878K | Buy |
|
|||||
|
2019
Q4 | $1.7M | Buy |
|
|||||
|
2019
Q3 | $1.36M | Buy |
|
|||||
|
2019
Q2 | $1.2M | Buy |
|
|||||
|
2019
Q1 | $1.15M | Buy |
|
|||||
|
2018
Q4 | $885K | Buy |
|
|||||
|
2018
Q3 | $923K | Sell |
|
|||||
|
2018
Q2 | $857K | Buy |
|
|||||
|
2018
Q1 | $739K | Buy |
|
|||||
|
2017
Q4 | $592K | Sell |
|
|||||
|
2017
Q3 | $610K | Hold |
|
|||||
|
2017
Q2 | $592K | Sell |
|
|||||
|
2017
Q1 | $535K | Hold |
|
|||||
|
2016
Q4 | $532K | Sell |
|
|||||
|
2016
Q3 | $593K | Buy |
|
|||||
|
2016
Q2 | $573K | Hold |
|
|||||
|
2016
Q1 | $503K | Buy |
|
|||||
|
2015
Q4 | $512K | Buy |
|
|||||
|
2015
Q3 | $461K | Hold |
|
|||||
|
2015
Q2 | $562K | Hold |
|
|||||
|
2015
Q1 | $487K | Hold |
|
|||||
|
2014
Q4 | $434K | Hold |
|
|||||
|
2014
Q3 | $356K | Hold |
|
|||||
|
2014
Q2 | $426K | Hold |
|
|||||
|
2014
Q1 | $419K | Hold |
|
|||||
|
2013
Q4 | $410K | Hold |
|
|||||
|
2013
Q3 | $328K | Buy |
|
|||||
|
2013
Q2 | $286K | Buy |
|